1st Edition

Vaccination Programmes
Epidemiology, Monitoring, Evaluation




  • Available for pre-order. Item will ship after September 14, 2021
ISBN 9781138054851
September 14, 2021 Forthcoming by Routledge
82 B/W Illustrations

USD $48.95

Prices & shipping based on shipping country


Preview

Book Description

Vaccination programmes are of vital importance to public health and are present in virtually every country in the world. By promoting an understanding of the diverse effects of vaccination programmes, this textbook discusses how epidemiologic methods can be used to study, in real life, their impacts, benefits and risks.

Written by expert practitioners in an accessible and concise style, this book is interspersed with practical examples which allow readers to acquire understanding through real life data and problems.Section I provides an overview of basic concepts in vaccinology, immunology, vaccination programmes, infectious disease transmission dynamics, the various impacts of vaccination programmes and their societal context. Section II covers the main field tools used for the epidemiological evaluation of vaccination programmes: Monitoring coverage and attitudes towards vaccination, surveillance of vaccine preventable diseases and pathogens, seroepidemiological studies, methods to assess impact and outbreak investigation. Section III is dedicated to vaccine effectiveness, and its assessment. Section IV includes an overview of the potential risks of vaccination and how to the study these. Lastly, Section V deals with methods for an integrated assessment of benefits and risks of vaccination programmes. Suitable for professionals working in public health, epidemiology, biology, and those working in health economics and vaccine development, Vaccination Programmes also serves as a textbook for postgraduate students in public health, epidemiology and infectious diseases.

The book is aimed at all those involved in the many aspects of vaccination programmes, including public health professionals and epidemiologists. Its primary target audiences are master and doctoral students in infectious disease epidemiology and public health, post-doctoral participants of field epidemiology training programmes and public health professionals working in the post-implementation epidemiological evaluation of vaccines and vaccination programmes.

 

Table of Contents

Part I: Background  1.Vaccines  2.How vaccines work  3.Vaccination programmes  4.Dynamics of controlling vaccine preventable diseases  5.Impact of mass vaccination programmes  6.Vaccine risks: a societal perspective  Part II: Field Tools for Monitoring Vaccination Programmes  7.Monitoring vaccine coverage and attitudes towards vaccination  8.Surveillance of vaccine preventable diseases and pathogens  9.Serological surveillance  10.Assessing impact  11.Outbreak investigation of vaccine preventable diseases  Part III: Vaccine Effectiveness  12.Vaccine effectiveness  13.Estimating vaccine effectiveness: General methodological principles  14.Estimating vaccine effectiveness: Cohort and household contact studies  15.Estimating vaccine effectiveness: Case-control and screening studies  16.Waning vaccine effectiveness and models of vaccine action  Part IV: Risks Associated with Vaccination Programmes  17.Vaccine safety: an introduction  18.Surveillance of adverse events following immunisation  19.Estimating vaccination risks: general methodological principles  20.Epidemiological study designs for evaluating vaccine safety  Part V: Benefit-Risk Assessment of Vaccination Programmes  21.Benefit-risk assessment of vaccination programmes

...
View More

Author(s)

Biography

Susan Hahné is senior epidemiologist in the national immunisation programme department at the Centre for Epidemiology and Surveillance of Infectious diseases of the National Institute for Public Health and the Environment (RIVM) in the Netherlands.

Paddy Farrington is emeritus professor of statistics at the Open University (OU), UK. Prior to joining the OU in 1998, he was for 11 years statistician at the Immunisation Division of the Communicable Disease Surveillance Centre.

Kaatje Bollaerts is head of data science at P95 Belgium, a scientific service-providing company focused on pharmacovigilance and epidemiology related to vaccines and infectious diseases.